Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Assets: 2018-2021

  • Genmab A's Assets rose 25.01% to $2,670 in Q2 2021 from the same period last year, while for Jun 2021 it was $2,670, marking a year-over-year increase of 25.01%. This contributed to the annual value of $2.4 billion for FY2020, which is 55.39% up from last year.
  • Latest data reveals that Genmab A reported Assets of $2,670 as of Q2 2021, which was down 100.00% from $2.4 billion recorded in Q4 2020.
  • In the past 5 years, Genmab A's Assets ranged from a high of $2.4 billion in Q4 2020 and a low of $2,136 during Q2 2020.
  • Its 3-year average for Assets is $987.6 million, with a median of $951.0 million in 2019.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 66.88% in 2019, then slumped by 100.00% in 2020.
  • Quarterly analysis of 4 years shows Genmab A's Assets stood at $935.5 million in 2018, then soared by 66.88% to $1.6 billion in 2019, then spiked by 55.39% to $2.4 billion in 2020, then increased by 25.01% to $2,670 in 2021.
  • Its last three reported values are $2,670 in Q2 2021, $2.4 billion for Q4 2020, and $2,136 during Q2 2020.